PDCD1 and neoplasm: Our findings reveal that ARRB1 deficiency in the host microenvironment dramatically enhances anti-tumor immunity through multiple mechanisms, including increased T cell infiltration and activation, reduced MDSC accumulation, and decreased expression of the exhaustion marker PD-1.